(Q33405115)

26 July 2017

title

Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases (English)

1 reference

26 July 2017

1 reference

1 reference

Mario Ojeda-Uribe

1

0 references

author name string

Naji Afif

2

1 reference

26 July 2017

Etienne Dahan

3

1 reference

26 July 2017

Laetitia Sparsa

4

1 reference

26 July 2017

Celine Haby

5

1 reference

26 July 2017

Jean Sibilia

6

1 reference

26 July 2017

David Ternant

7

1 reference

26 July 2017

Marc Ardizzone

8

1 reference

26 July 2017

publication date

5 January 2013

1 reference

26 July 2017

published in

Clinical Rheumatology

1 reference

26 July 2017

volume

32

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

695-700

1 reference

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Dynamics of immunoglobulins at the feto-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

FcRn: the MHC class I-related receptor that is more than an IgG transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Pregnancy outcomes after maternal exposure to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Cytokines and T cells in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Abatacept therapy and safety management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The double life of a B-1 cell: self-reactivity selects for protective effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Treatment with biologics of pregnant patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The role of gender and organ specific autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Pharmacokinetics of rituximab and its clinical use: thought for the best use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Biologic therapy and pregnancy outcomes in women with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial

21 January 2018

1 reference

12 December 2020

Administration of rituximab during the first trimester of pregnancy without consequences for the newborn

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy

1 reference

12 December 2020

Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy

1 reference

12 December 2020

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

1 reference

12 December 2020

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.

1 reference

12 December 2020

Rituximab (MabThera) therapy and safety management. Clinical tool guide

1 reference

12 December 2020

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

1 reference

12 December 2020

Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

The effects of rituximab treatment during pregnancy on a neonate

1 reference

12 December 2020

Disparities in rates of unintended pregnancy in the United States, 1994 and 2001

1 reference

12 December 2020

10.1007/S10067-012-2156-4

Identifiers

DOI

1 reference

26 July 2017

1 reference